For in vitro diagnostic use. Others Elecsys PAPP-A IVD Elecsys® PAPP-A CPS_000495 08 860 173 190 8 860 173 190 08860173190 8860173190 08860173190 PAPP-A Elecsys cobas e 100 V2 Elecsys PAPP-A 07613336168882 Reagents, kits 100 tests cobas e 411/601/602 true 08 860 181 190 8 860 181 190 08860181190 8860181190 08860181190 PAPP-A Elecsys E2G 100 V2 Elecsys PAPP-A 07613336168899 Reagents, kits 100 tests cobas e 402/801 true 07 027 621 190 7 027 621 190 07027621190 7027621190 07027621190 PAPP-A Elecsys E2G 100 Elecsys PAPP-A 04015630940233 Reagents, kits 100 tests cobas e 402/801 true 08860173500 Elecsys PAPP-A en 3 FF00000005B1130E FF000000038C350E 08860173190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of pregnancy-associated plasma protein A in human serum.This assay is intended for the use as one component in combination with other parameters to evaluate the risk of trisomy 21 (Down syndrome) during the first trimester of pregnancy. Further testing is required for diagnosis of chromosomal aberrations.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 08860181500 Elecsys PAPP-A en 5 FF00000005CCF00E FF0000000449E10E 08860181190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of pregnancy-associated plasma protein A in human serum.This assay is intended for the use as one component in combination with other parameters to evaluate the risk of trisomy 21 (Down syndrome) during the first trimester of pregnancy. Further testing is required for diagnosis of chromosomal aberrations.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 07027621500 Elecsys PAPP-A en 3 FF00000002479F0E FF00000001974D0E 07027621190 2497 cobas e 801 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of pregnancy-associated plasma protein A in human serum.This assay is intended for the use as one component in combination with other parameters to evaluate the risk of trisomy 21 (Down syndrome) during the first trimester of pregnancy. Further testing is required for diagnosis of chromosomal aberrations.The electrochemiluminescence immunoassay “ECLIA” is intended for use on the cobas e 801 immunoassay analyzer. en

User Profile

Select your user profile

Elecsys^® PAPP-A

Overview

Ordering Information

Technical Documents

Access important product documentation including relevant certificates and other resources.

Compatible Instruments

Related products

Contact us